Target intelligence / Profile preview

Yes-associated protein 1 mRNA 3' untranslated region (YAP1 mRNA 3' UTR)

Target
YAP1 mRNA 3' UTR
Molecular classification
RNA, Messenger RNA (mRNA), Untranslated region (UTR)
01

Overview

The Yes-associated protein 1 (YAP1) mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the YAP1 transcript that governs the stability, localization, and translation efficiency of the YAP1 protein [1, 11]. As a central effector of the Hippo signaling pathway, YAP1 plays a pivotal role in organ size control, cell proliferation, and stem cell maintenance [10, 14]. The 3' UTR contains numerous binding sites for microRNAs (miRNAs) and RNA-binding proteins, such as hnRNP F, which can induce alternative splicing or degradation of the mRNA to modulate YAP1 levels [3, 7]. Dysregulation of YAP1, often through the loss of these inhibitory controls in the 3' UTR, is a hallmark of various cancers, including hepatocellular carcinoma and lung cancer, where it drives tumor progression and chemoresistance [6, 12, 17]. Consequently, the YAP1 mRNA 3' UTR has emerged as a therapeutic target for antisense oligonucleotides (ASOs) and RNA-based therapies designed to reduce oncogenic YAP1 expression [2, 9]. For example, the ASO ION-537 is designed to bind specifically to the YAP1 transcript to induce its degradation, thereby reducing the levels of this potent oncogene in tumors [9].

Other names
YAP1 3' UTRYAP 3' UTRYes-associated protein 1 3'-UTRYAP1 3' untranslated regionYAP1 mRNA 3'-UTR
02

Mechanism of action

Antisense inhibition, RNA interference (RNAi), miRNA-mediated silencing, mRNA degradation, Splicing modulation

03

Biological functions

Regulation of gene expressionmRNA stabilityTranslation regulationAlternative splicingmRNA localizationmiRNA-mediated silencing
04

Disease associations

CancerHepatocellular carcinomaLung cancerBreast cancerEsophageal cancerRenal fibrosisCardiac fibrosis
05

Safety considerations

Off-target effects of RNA-targeting drugsImpaired tissue regeneration and wound healingSystemic toxicity of delivery vehiclesPotential for over-suppression of physiological Hippo signaling
06

Interacting drugs

ION-537 (IONIS-YAP1Rx)

2 more in the full profile.

07

Biomarkers

YAP1 mRNA levelsYAP1 protein levelsmiR-375 expressionNuclear YAP1 localization

Beyond the preview

Go deeper on Yes-associated protein 1 mRNA 3' untranslated region (YAP1 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yes-associated protein 1 mRNA 3' untranslated region (YAP1 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call